首页> 美国卫生研究院文献>other >Early-stage epigenetic modification during somatic cell reprogramming by Parp1 and Tet2
【2h】

Early-stage epigenetic modification during somatic cell reprogramming by Parp1 and Tet2

机译:由paRp1和TET2体细胞重新编程期间早期表观遗传修饰

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Somatic cells can be reprogrammed into induced pluripotent stem cells (iPSCs) by using the pluripotency factors Oct4, Sox2, Klf4 and c-Myc (together referred to as OSKM). iPSC reprogramming erases somatic epigenetic signatures—as typified by DNA methylation or histone modification at silent pluripotency loci—and establishes alternative epigenetic marks of embryonic stem cells (ESCs). Here we describe an early and essential stage of somatic cell reprogramming, preceding the induction of transcription at endogenous pluripotency loci such as Nanog and Esrrb. By day 4 after transduction with OSKM, two epigenetic modification factors necessary for iPSC generation, namely poly(ADP-ribose) polymerase-1 (Parp1) and ten-eleven translocation-2 (Tet2), are recruited to the Nanog and Esrrb loci. These epigenetic modification factors seem to have complementary roles in the establishment of early epigenetic marks during somatic cell reprogramming: Parp1 functions in the regulation of 5-methylcytosine (5mC) modification, whereas Tet2 is essential for the early generation of 5-hydroxymethylcytosine (5hmC) by the oxidation of 5mC (refs ,). Although 5hmC has been proposed to serve primarily as an intermediate in 5mC demethylation to cytosine in certain contexts, our data, and also studies of Tet2-mutant human tumour cells, argue in favour of a role for 5hmC as an epigenetic mark distinct from 5mC. Consistent with this, Parp1 and Tet2 are each needed for the early establishment of histone modifications that typify an activated chromatin state at pluripotency loci, whereas Parp1 induction further promotes accessibility to the Oct4 reprogramming factor. These findings suggest that Parp1 and Tet2 contribute to an epigenetic program that directs subsequent transcriptional induction at pluripotency loci during somatic cell reprogramming.
机译:使用多能性因子Oct4,Sox2,Klf4和c-Myc(统称为OSKM) ,可以将体细胞重编程为诱导性多能干细胞(iPSC)。 iPSC重编程消除了体细胞表观遗传学特征(以沉默多能位点处的DNA甲基化或组蛋白修饰为代表),并建立了胚胎干细胞(ESC)的替代表观遗传学标记 。在这里,我们描述了在内源多能性位点(例如Nanog和Esrrb)诱导转录之前,体细胞重编程的早期和必要阶段。在用OSKM转导后的第4天,iPSC生成所需的两个表观遗传修饰因子,即聚(ADP-核糖)聚合酶-1(Parp1)和十一个11易位2(Tet2),被募集到Nanog和Esrrb基因座。这些表观遗传修饰因子似乎在体细胞重编程期间的早期表观遗传标记的建立中具有互补的作用:Parp1在调节5-甲基胞嘧啶(5mC)修饰中起作用,而Tet2对于5-羟甲基胞嘧啶(5hmC)的早期生成至关重要被5mC氧化(参考)。尽管有人提议在某些情况下5hmC主要用作5mC胞嘧啶去甲基化的中间体,但我们的数据以及对Tet2突变的人类肿瘤细胞的研究 认为有利于5hmC作为不同于5mC的表观遗传标记。与此一致,早期建立组蛋白修饰(分别代表多能性位点处的活化染色质状态)分别需要Parp1和Tet2,而Parp1诱导则进一步促进了Oct4重编程因子的可及性。这些发现表明,Parp1和Tet2有助于表观遗传程序,该程序在体细胞重编程过程中指导多能性位点的后续转录诱导。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号